These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 14734478
1. Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase. Sumitomo M, Asano T, Asakuma J, Asano T, Nanus DM, Hayakawa M. Clin Cancer Res; 2004 Jan 01; 10(1 Pt 1):260-6. PubMed ID: 14734478 [Abstract] [Full Text] [Related]
2. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation. Sumitomo M, Shen R, Goldberg JS, Dai J, Navarro D, Nanus DM. Cancer Res; 2000 Dec 01; 60(23):6590-6. PubMed ID: 11118039 [Abstract] [Full Text] [Related]
3. Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. Sumitomo M, Ohba M, Asakuma J, Asano T, Kuroki T, Asano T, Hayakawa M. J Clin Invest; 2002 Mar 01; 109(6):827-36. PubMed ID: 11901191 [Abstract] [Full Text] [Related]
4. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling. Sumitomo M, Shen R, Walburg M, Dai J, Geng Y, Navarro D, Boileau G, Papandreou CN, Giancotti FG, Knudsen B, Nanus DM. J Clin Invest; 2000 Dec 01; 106(11):1399-407. PubMed ID: 11104793 [Abstract] [Full Text] [Related]
5. Androgen-induced growth inhibition of androgen receptor expressing androgen-independent prostate cancer cells is mediated by increased levels of neutral endopeptidase. Shen R, Sumitomo M, Dai J, Harris A, Kaminetzky D, Gao M, Burnstein KL, Nanus DM. Endocrinology; 2000 May 01; 141(5):1699-704. PubMed ID: 10803579 [Abstract] [Full Text] [Related]
6. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, Finstad CL, Reuter VE, Powell CT, Scheinberg D, Magill C, Scher HI, Albino AP, Nanus DM. Nat Med; 1998 Jan 01; 4(1):50-7. PubMed ID: 9427606 [Abstract] [Full Text] [Related]
7. Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells. Dai J, Shen R, Sumitomo M, Goldberg JS, Geng Y, Navarro D, Xu S, Koutcher JA, Garzotto M, Powell CT, Nanus DM. Clin Cancer Res; 2001 May 01; 7(5):1370-7. PubMed ID: 11350908 [Abstract] [Full Text] [Related]
8. Methylation of the neutral endopeptidase gene promoter in human prostate cancers. Usmani BA, Shen R, Janeczko M, Papandreou CN, Lee WH, Nelson WG, Nelson JB, Nanus DM. Clin Cancer Res; 2000 May 01; 6(5):1664-70. PubMed ID: 10815884 [Abstract] [Full Text] [Related]
9. Corn silk maysin induces apoptotic cell death in PC-3 prostate cancer cells via mitochondria-dependent pathway. Lee J, Lee S, Kim SL, Choi JW, Seo JY, Choi DJ, Park YI. Life Sci; 2014 Dec 05; 119(1-2):47-55. PubMed ID: 25445226 [Abstract] [Full Text] [Related]
10. Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta. Fujii T, García-Bermejo ML, Bernabó JL, Caamaño J, Ohba M, Kuroki T, Li L, Yuspa SH, Kazanietz MG. J Biol Chem; 2000 Mar 17; 275(11):7574-82. PubMed ID: 10713064 [Abstract] [Full Text] [Related]
11. Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines. Usmani BA, Harden B, Maitland NJ, Turner AJ. Clin Sci (Lond); 2002 Aug 17; 103 Suppl 48():314S-317S. PubMed ID: 12193112 [Abstract] [Full Text] [Related]
12. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells. Song J, Aumüller G, Xiao F, Wilhelm B, Albrecht M. Prostate; 2004 Mar 01; 58(4):394-405. PubMed ID: 14968440 [Abstract] [Full Text] [Related]
13. Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells. Reyland ME, Anderson SM, Matassa AA, Barzen KA, Quissell DO. J Biol Chem; 1999 Jul 02; 274(27):19115-23. PubMed ID: 10383415 [Abstract] [Full Text] [Related]
14. Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide. Mimeault M, Venkatraman G, Johansson SL, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK. Int J Cancer; 2007 Jan 01; 120(1):160-9. PubMed ID: 17013895 [Abstract] [Full Text] [Related]
15. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway. Sumitomo M, Milowsky MI, Shen R, Navarro D, Dai J, Asano T, Hayakawa M, Nanus DM. Cancer Res; 2001 Apr 15; 61(8):3294-8. PubMed ID: 11309283 [Abstract] [Full Text] [Related]
16. Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells. Mandil R, Ashkenazi E, Blass M, Kronfeld I, Kazimirsky G, Rosenthal G, Umansky F, Lorenzo PS, Blumberg PM, Brodie C. Cancer Res; 2001 Jun 01; 61(11):4612-9. PubMed ID: 11389098 [Abstract] [Full Text] [Related]
17. Expression and immunolocalisation of neutral endopeptidase in prostate cancer. Albrecht M, Mittler A, Wilhelm B, Lundwall A, Lilja H, Aumüller G, Bjartell A. Eur Urol; 2003 Oct 01; 44(4):415-22. PubMed ID: 14499674 [Abstract] [Full Text] [Related]
18. Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status. Serafin AM, Akudugu JM, Bohm L. Urol Res; 2002 Oct 01; 30(5):289-94. PubMed ID: 12389116 [Abstract] [Full Text] [Related]
19. Targeting protein kinase C (PKC) and telomerase by phenethyl isothiocyanate (PEITC) sensitizes PC-3 cells towards chemotherapeutic drug-induced apoptosis. Mukherjee S, Bhattacharya RK, Roy M. J Environ Pathol Toxicol Oncol; 2009 Oct 01; 28(4):269-82. PubMed ID: 20102325 [Abstract] [Full Text] [Related]
20. Identification and characterization of two androgen response regions in the human neutral endopeptidase gene. Shen R, Sumitomo M, Dai J, Hardy DO, Navarro D, Usmani B, Papandreou CN, Hersh LB, Shipp MA, Freedman LP, Nanus DM. Mol Cell Endocrinol; 2000 Dec 22; 170(1-2):131-42. PubMed ID: 11162897 [Abstract] [Full Text] [Related] Page: [Next] [New Search]